Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Amazon Explores AI Content Marketplace With Media Publishers 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
NEW YORK, Dec. 18, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of INC Research Holdings, Inc. (NASDAQ:INCR) who purchased shares between May 10, 2017 and November 9, 2017. The action, which was filed in the United States District Court for the Southern District of New York, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) the merger with inVentiv Health, Inc. ("inVentiv") was not providing the benefit that defendants stated it would; (2) inVentiv was underperforming; (3) in turn, INCR's 2017 financial performance would be negatively impacted; and (4) as a result, defendants’ statements about INCR's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
Shareholders have until January 30, 2018 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sb/inc-research-holdings-inc?wire=3.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
